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Fig. S1. Positive CPT signal in posttreatment tumor tissues. Posttreatment tumor images are 
shown for remaining patients not included in the main text. White arrows indicate examples of 
CPT signal. 
 
Fig. S2. CPT signal shows significant decrease with sequential laser scans. Points of positive 
CPT signal in the 1st scan which are absent in a 2nd scan of the same tissue area are indicated by 
white arrows. The majority of CPT signal is absent upon the 2nd laser scan. 
  
 
Fig. S3. Potential positive CPT signal (purple dots) in patient 8 posttreatment non-neoplastic 
tissue. Areas of potential CPT signal that did not diminish upon multiple confocal laser scans are 
indicated with white arrows. A bubble within the tissue section identified with a brightfield image 
is indicated with the BU label. The overall decrease in CPT signal in this tissue area was not as 
pronounced as that observed in the posttreatment tumor tissues (Fig. S2) so this tissue was not 
determined to contain definitive CPT signal. 
 
  
 
 
 
 
Fig. S4. H&E stain of biopsy series from a single patient. Sections of entire tissue biopsy for pre-
treatment non-neoplastic (A1), pretreatment tumor (B1), posttreatment non-neoplastic (C1) and 
posttreatment tumor (D1) tissues are shown. The image in the right column (X-2) contains a high-
magnification image of the area indicated by the box overlaying the corresponding full tissue 
section.  
